2006;27:808 16. 782. Johnson JA, Zineh I, Puckett BJ, et al. Beta adrenergic receptor poly- morphisms and antihypertensive response to metoprolol. Clin Pharmacol Ther. 2003;74:44 52. 783. Liu J, Liu ZQ, Yu BN, et al. beta Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension. Clin Pharmacol Ther. 2006;80:23 32. 784. Karlsson J, Lind L, Hallberg P, et al. Beta adrenergic receptor gene polymorphisms and response to beta adrenergic receptor blockade in patients with essential hypertension. Clin Cardiol. 2004;27:347 50. 785. O Shaughnessy KM, Fu B, Dickerson C, et al. The gain-of-function G389R variant of the beta adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects. Clin Sci (Lond). 2000;99:233 8. 786. Rehnqvist N, Hjemdahl P, Billing E, et al. Treatment of stable angina pectoris with calcium antagonists and beta-blockers. The APSIS study. Angina Prognosis Study in Stockholm. Cardiologia. 1995;40:301. 787. von Arnim T. Medical treatment to reduce total ischemic burden: total ischemic burden bisoprolol study (TIBBS), a multicenter trial com- paring bisoprolol and nifedipine. The TIBBS Investigators. J Am Coll Cardiol. 1995;25:231 8. 788. Savonitto S, Ardissiono D, Egstrup K, et al. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study. J Am Coll Cardiol. 1996;27:311 6. 789. Emanuelsson H, Egstrup K, Nikus K, et al. Antianginal efficacy of the combination of felodipine-metoprolol 10/100 mg compared with each drug alone in patients with stable effort-induced angina pectoris: a multicenter parallel group study. The TRAFFIC Study Group. Am Heart J. 1999;137:854 62. 790. Waysbort J, Meshulam N, Brunner D. Isosorbide mononitrate and atenolol in the treatment of stable exertional angina. Cardiology. 1991;79 Suppl 2:19 26. 791. Krepp HP. 